Cancer Nanotheranostics

2015
ISBN: 978-981-287-434-4
Verlag: Springer Nature Singapore

Buch, Englisch, 119 Seiten, Format (B × H): 155 mm x 235 mm, Gewicht: 2175 g

Reihe: SpringerBriefs in Applied Sciences and Technology

This Brief provides a clear insight of the recent advances in the field of cancer theranostics with special emphasis upon nano scale carrier molecules (polymeric, protein and lipid based) and imaging agents (organic and inorganic).

Zielgruppe

Research

Autoren/Hrsg.

Gopinath, P.

Uday Kumar, S.

Matai, Ishita

Dubey, Poornima

Bhushan, Bharat

Malwal, Deepika

Sachdev, Abhay

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Innere Medizin
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Molekulare Medizin, Zellbiologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Technische Wissenschaften Sonstige Technologien | Angewandte Technik Medizintechnik, Biomedizintechnik
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizintechnik, Biomedizintechnik, Medizinische Werkstoffe

Inhaltsverzeichnis

Preface.- Acknowledgements.- Cancer Nanotheranostics.

Über Autor(innen)

Dr. P. Gopinath is an Assistant Professor in the Department of Biotechnology at Indian Institute of Technology (IIT) Roorkee, India. He received his B.Sc. degree in Microbiology and M.Sc. degree in Biotechnology from Bharathidasan University, India. He earned his Ph.D. in Biotechnology at Indian Institute of Technology Guwahati, India. He did his postdoctoral research at University of Rochester Medical Center, New York, USA. Currently his research group in nano biotechnology laboratory is working on the development of various protein and polymer based nano carriers for the delivery of various anticancer agents including anticancer drugs, siRNA, genes etc. This group is also exploring the possibilities of various biocompatible imaging agents for cancer diagnosis. In order to realize the efficacy of such therapeutic and imaging agents, they are validating these systems in an artificial scaffold which mimics the in vivo condition to the closest extent.